Table 2 Demographic and treatment characteristics of the sample
From: Efficacy of a referral center for patient-centered care in multiple myeloma: a cohort study
Variable | CRMM | Other | p |
|---|---|---|---|
(n = 19) n (%) | (n = 13) n (%) | ||
Sex | 0.471* | ||
Female | 10 (52.6 %) | 9 (69.2 %) | |
Male | 9 (47.4 %) | 4 (30.8 %) | |
Age at diagnosis, mean (standard deviation) | 55.3 (11.1) | 61.3 (11.2) | 0.145** |
Place of residence | 0.720* | ||
Porto Alegre | 7 (36.8 %) | 6 (46.2 %) | |
Other municipalities in Rio Grande do Sul | 12 (63.2 %) | 7 (53.8 %) | |
Thalidomide collection site | |||
HCPA | 19 (100 %) | ||
Municipal pharmacy | 9 (69.2 %) | ||
SHD pharmacy | 4 (30.8 %) | ||
Treatment duration in months, median (IQR) | 20 (12–36) | 24 (12–36) | 0.248*** |
Educational attainment | 0.351* | ||
Primary education | 9 (52.9 %) | 3 (25.0 %) | |
Secondary education | 5 (29.4 %) | 6 (50.0 %) | |
Higher education | 3 (17.6 %) | 3 (25.0 %) |